Codes / ICD10CM / T50.7X3D

T50.7X3D Poisoning by analeptics and opioid receptor antagonists, assault, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by analeptics and opioid receptor antagonists, assault, subsequent encounter

Summary

This condition involves harmful effects resulting from exposure to analeptics (stimulant medications) or opioid receptor antagonists (drugs that block opioid effects) due to assault, with the encounter occurring during the recovery phase. It includes poisoning or adverse reactions caused by intentional administration of these substances by another party, which can disrupt central nervous system function, respiratory regulation, and opioid-related pathways. The "subsequent encounter" designation indicates ongoing care for sequelae or complications following the initial event.

Causes

Exposure typically results from deliberate administration of these medications by another individual, often as part of an assault. Therapeutic errors or drug interactions may exacerbate effects, but the primary cause is intentional action by a third party. The subsequent encounter reflects continued management of residual effects or complications from the initial poisoning.

Risk Factors

  • Exposure to environments where assault is possible (e.g., violent or unsafe settings)
  • Lack of supervision or control over medication access in vulnerable situations
  • Concurrent use of medications altering CNS activity or opioid effects
  • Underlying conditions requiring analeptic or antagonist therapy (increasing target for assault)
  • Delayed or incomplete resolution of initial poisoning effects requiring ongoing care

Symptoms

  • Central nervous system effects (e.g., agitation, seizures, sedation, confusion)
  • Respiratory changes (e.g., tachypnea, respiratory depression, or paradoxical stimulation)
  • Cardiovascular instability (e.g., hypertension, hypotension, arrhythmias)
  • Gastrointestinal disturbances (nausea, vomiting)
  • Altered mental status or confusion
  • Persistent or recurrent symptoms from initial poisoning

Diagnosis

Diagnosis involves patient history to identify the assault-related exposure and subsequent encounter context, along with clinical evaluation of residual symptoms. Laboratory tests may assess drug levels or metabolic markers, while imaging or other studies rule out complications. Documentation must confirm the assault as the cause and the encounter as subsequent to the initial event.

Treatment Options

Management focuses on addressing residual symptoms and preventing further complications. This may include monitoring vital signs, administering supportive care (e.g., airway management, fluid resuscitation), and treating specific effects (e.g., anticonvulsants for seizures). Ongoing assessment ensures resolution of acute effects and addresses any chronic sequelae.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial poisoning and the effectiveness of subsequent care. Follow-up involves monitoring for lingering neurological, respiratory, or cardiovascular effects, with adjustments to treatment as needed. Regular evaluations help detect and manage long-term complications.

Complications

  • Persistent neurological deficits (e.g., cognitive impairment, seizures)
  • Chronic respiratory dysfunction
  • Cardiovascular instability or arrhythmias
  • Gastrointestinal complications (e.g., prolonged nausea, vomiting)
  • Psychological effects from the assault (e.g., trauma-related disorders)

Lifestyle & Prevention

  • Avoid high-risk environments to reduce assault exposure
  • Ensure secure storage of medications to prevent unauthorized access
  • Follow prescribed medication regimens to minimize therapeutic errors
  • Seek counseling or support for trauma-related psychological effects
  • Maintain open communication with healthcare providers about ongoing symptoms

When to Seek Professional Help

Seek immediate care if symptoms worsen (e.g., severe respiratory distress, uncontrolled seizures, or cardiovascular instability) or if new complications arise. Ongoing follow-up is necessary for persistent symptoms or delayed effects.

Tips for Medical Coders

Document the assault as the cause of poisoning and confirm the encounter is subsequent to the initial event. Ensure clinical notes specify residual effects or complications requiring ongoing care. Code T50.7X3D is appropriate when the poisoning resulted from assault and the encounter occurs during the recovery phase.

Book a walkthrough

T50.7X3D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.